Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Farhad Hafezi

Farhad Hafezi

As a post-doc, Farhad Hafezi identified a gene that can completely inhibit light-induced retinal damage in mice. Today his clinical focus is on corneal and refractive laser surgery, and he is a pioneer of corneal collagen cross-linking (CXL). Hafezi was instrumental in building IROC in Zurich, where CXL technology underwent further clinical development.

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register